supported by the Michael J.Fox Foundation for Parkinson’s Research(MJFF)grant 16879(M.X.H)and Aligning Science Across Parkinson’s ASAP-020616 through MJFF;NIH grants:R01-AG077573(D.S.B,M.X.H.);NSF grants PHY-1554488(D.S.B)and BCS-1631550(D.S.B).D.S.B.also acknowledges support from the John D.and Catherine T.MacArthur Foundation,the ISI Foundation,the Alfred P.Sloan Foundation,and the Paul G.Allen Foundation.
Background Mutations in leucine-rich repeat kinase 2(LRRK2)are the most common cause of familial Parkinson’s disease(PD).These mutations elevate the LRRK2 kinase activity,making LRRK2 kinase inhibitors an attractive ...
supported by grants from the Region Occitanie/Pyrenees-Mediterranee(No.1901175);the European Regional Development Fund(ERDF)(project No.MP0022856);received funds from Alzheimer Prevention in Occitania and Catalonia(APOC Chair of Excellence-Inspire Program);supported by grants from the Gerontopole of Toulouse,French Ministry of Health(PHRC 2008 and PHRC 2009);Pierre Fabre Research Institute(manufacturer of the omega-3 supplement);Exonhit Therapeutics SA;Avid Radiopharmaceuticals Inc;supported by the University Hospital Center of Toulouse;supported by the Association Monegasque pour la Recherche sur la maladie d’Alzheimer(AMPA);the INSERM-University of ToulouseⅢUMR 1027 Unit。
Background:Age-related changes in brain structure may constitute the starting point for cerebral function alteration.Physical activity(PA)demonstrated favorable associations with total brain volume,but its relationshi...